Oscar Segurado | Chief Medical Officer
Asc Therapeutics

Oscar Segurado, Chief Medical Officer, Asc Therapeutics

Executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development and global medical affairs.
C-suite executive and industry leader providing in-depth expertise for pre-clinical and clinical study strategy, planning, execution and monitoring, regulatory interactions, investor relations, fundraising, M&A and IPO process and deliverables. 
Chief Medical Officer for ASC Therapeutics, former CMO for Symvivo, Myriad Genetics and CellMax Life, Vice President for Becton Dickinson and Global Medical Head for Abbott/AbbVie (Humira).
Author and co-author of over 100 peer-reviewed publications, including Nature, Lancet and Journal of Experimental Medicine, books and medical articles and member of several scientific and medical societies.
Holding a tenured Professorship of Immunology at the University of Leon, Spain. Received PhD from the University of Wuerzburg, Germany and MD from the University of Salamanca, Spain


Festival of Biologics Day 2 @ 14:40

Integration of clinical and biomarker data in gene therapy clinical trials

Festival of Biologics Day 2 @ 17:30

Biomarkers and Key Drivers of Drug Development in Gene Therapy

last published: 21/Sep/23 16:38 GMT

back to speakers